Anju Software

🔬 Navigating Rare Disease Trials with Smarter Strategies 🌍 Rare disease trials face small patient populations, investigator scarcity, and data gaps—but TA Scan helps sponsors overcome these challenges. With real-time insights, we make it easier to find experts, expand networks, and accelerate trial success. 💡 Smarter trial planning starts here. Learn how TA Scan is transforming rare disease research. 🔗 Read more:

Is your clinical trial ready to face the “big bad wolf” of feasibility issues? 🐺 🏆 Best in Show Winner at SCOPE 2025, Anju is bringing you an exclusive webinar: 📢 The Three Little Pigs’ Tale: A Strategic Approach to Clinical Trial Feasibility Join industry leaders Elke Ydens & Barbara Argibay Gonzalez as they tackle: ✅ Building precise enrollment models to improve trial success rates ✅ Optimizing site selection for efficiency and speed ✅ Planning for unforeseen challenges to avoid costly delays 📅 Date: February 25, 2025 | ⏰ Time: 10 AM EST | 4 PM CET | 7 AM PST 🔹 Register now – don’t let enrollment challenges slow you down! https://lnkd.in/gCphSPTB

🌍 Overcoming Rare Disease Trial Challenges with TA Scan 🌍 Rare disease trials face unique hurdles—small patient populations, limited data, and investigator scarcity. TA Scan helps sponsors find the right experts, expand networks, and optimize trial strategies with real-time intelligence. 🔎 Key Benefits: ✅ Identify rising investigators & niche experts ✅ Expand reach beyond major centers ✅ Leverage data-driven trial planning 💡 Innovation is key to breakthroughs in rare disease research. Learn how TA Scan is making an impact. 🔗 Read more:

📢 𝗝𝗼𝗶𝗻 𝗔𝗻𝗷𝘂 𝗮𝘁 𝗗𝗜𝗔’𝘀 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗮𝗻𝗱 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 conference! 📍 𝗠𝗮𝗿𝗰𝗵 𝟭𝟬-𝟭𝟮 | 𝗕𝗼𝘀𝘁𝗼𝗻, 𝗠𝗔 | 𝗕𝗼𝗼𝘁𝗵 𝟮𝟬𝟭 🔹 𝗠𝗲𝗲𝘁 𝗔𝗻𝗷𝘂’𝘀 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗲𝘅𝗽𝗲𝗿𝘁𝘀: 👥 Tyler Gill, Greg Flett-Davies, and Erick Borg will be on-site to share insights on navigating the rapidly changing technology landscape, meeting customer expectations, and optimizing medical communications. Stop by 𝗕𝗼𝗼𝘁𝗵 𝟮𝟬𝟭 to explore how Anju’s Medical Affairs suite can support your team with innovative solutions. #MASC25 #MedicalAffairs #ScientificCommunications #medicalinformation #MedicalCommunication #MSL #KOLs

OCT getting started. Stop by booth 43 if your at the show.

📍 We’re live at OCT West Coast in Burlingame! Stop by 𝗕𝗼𝗼𝘁𝗵 𝟰𝟯 to meet David Kirschenbaum and Ruben Echandy to discover how our eClinical and Data Science solutions, like TrialMaster and CTMS Master, can transform your clinical trial processes. Let’s talk innovation, collaboration, and the future of clinical research. We’re excited to connect with industry leaders and share ideas—don’t miss out! #OCTWestCoast #ClinicalTrials #Outsourcing #healthcare #pharma

Running clinical trials is though in any therapeutic area, but epilepsy trials present some unique hurdles: - 𝗛𝗲𝘁𝗲𝗿𝗼𝗴𝗲𝗻𝗼𝘂𝘀 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻 – Different epilepsy syndromes, seizure types, and drug-resistant cases make enrollment difficult. - 𝗠𝗲𝗮𝘀𝘂𝗿𝗶𝗻𝗴 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝗶𝘀 𝗰𝗼𝗺𝗽𝗹𝗲𝘅 – Seizure frequency fluctuated naturally, patient diaries aren’t always reliable, and EEG monitoring requires specialized sites. - 𝗦𝗨𝗗𝗘𝗣 𝗿𝗶𝘀𝗸 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝘀 𝗰𝗹𝗼𝘀𝗲 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 – Safety protocols must account for sudden unexpected death in epilepsy, adding complexity to trial design 🔍 Addressing these challenges starts with selecting the right sites and investigators: ✅ 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲𝗱 𝗰𝗲𝗻𝘁𝗲𝗿𝘀 – Sites with solid experience in epilepsy trials that can support, for instance, EEG monitoring for accurate seizure tracking and safety oversight. ✅ 𝗞𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲𝗮𝗯𝗹𝗲 𝗶𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗼𝗿𝘀 – Neurologists with epilepsy trial expertise can better assess efficacy and manage safety concerns like SUDEP risk. ✅ 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 – Understanding which sites and PIs that have the capacity to take on additional studies within the current competitive landscape. 💡 This is where TA Scan can help. With granular data on epilepsy trial history, investigator expertise, and site capacity insights, TA Scan helps teams find the right sites and investigators, assess feasibility, and strategically plan for enrollment success. Are you seeing these challenges in your epilepsy trials? Let’s chat. 👇 #ClinicalTrials #Epilepsy #InvestigatorSelection #DataDriven #EpilepsyDay #ClinicalOperations #DataScience #TAScan #ClinicalTrialSites 

✨ Thank You, SCOPE 2025! ✨ We’re still celebrating our 𝗕𝗲𝘀𝘁 𝗼𝗳 𝗦𝗵𝗼𝘄 𝘄𝗶𝗻 𝗮𝘁 𝗦𝗖𝗢𝗣𝗘 𝟮𝟬𝟮𝟱 and want to extend a huge thank you to everyone who voted for Anju Software and TA Scan Feasibility Flex! 🏆 Your support reinforces our commitment to driving smarter, data-driven clinical trial planning. If you missed us at the show, there's still time to learn how Feasibility Flex is transforming enrollment forecasting, site selection, and trial feasibility. 📢 𝗖𝗮𝘁𝗰𝗵 𝘂𝗽 𝗼𝗻 𝘁𝗵𝗲 𝗱𝗲𝘁𝗮𝗶𝗹𝘀 𝗮𝗻𝗱 𝘀𝗲𝗲 𝘄𝗵𝘆 𝘄𝗲 𝘄𝗼𝗻: https://lnkd.in/gyJgxvAV 📢 𝗦𝗶𝗴𝗻 𝘂𝗽 𝗳𝗼𝗿 𝗼𝘂𝗿 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝘁𝗼 𝘀𝗲𝗲 𝘄𝗵𝘆 𝗧𝗔 𝗦𝗰𝗮𝗻 𝗶𝘀 𝗮𝘄𝗮𝗿𝗱-𝘄𝗶𝗻𝗻𝗶𝗻𝗴: https://lnkd.in/gHMVSnQi

📢 The countdown is on—just a few days until OCT West Coast! ✨ Visit Anju at Booth 43 and meet with David Kirschenbaum and Ruben Echandy to explore our eClinical solutions, designed to optimize and accelerate your clinical trials. Don’t miss this chance to connect, collaborate, and discover the latest in clinical trial innovation. See you there! #OCTWestCoast #ClinicalTrials #Outsourcing #healthcare #pharma

𝗦𝗖𝗢𝗣𝗘 𝗕𝗲𝘀𝘁 𝗼𝗳 𝗦𝗵𝗼𝘄 𝗪𝗶𝗻𝗻𝗲𝗿𝘀 𝟮𝟬𝟮𝟱! Back-to-back wins for our data intelligence platform, TA Scan, and our Feasibility Flex Simulation Module. Taking the win in both 2024 and now 2025! Proud to be part of a team that’s driving innovation in clinical trial feasibility with our industry leading Feasibility Flex Simulation Module! What a time to be part of the Anju Software family! #Feasibility #ClinicalOperations #TAScan #AnjuSoftware #SCOPE2025 #DataAnalytics #TeamWork Barbara Argibay Gonzalez, Tim Lyons, John Coritz, Marta Plana Ramón, David Kirschenbaum, Laura Acosta